Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Rekentool voor afbouwen epilepsiemedicatie
mei 2017 | Epilepsie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen